US Bivalirudin Drug Market Growth Driven by Rising Cardiovascular Disease Burden
The Bivalirudin Drug Market in the US is supported by the high prevalence of cardiovascular diseases, increasing use of percutaneous coronary intervention, and well-established access to advanced cardiovascular care. Growing demand for effective anticoagulation during interventional cardiac procedures, along with the availability of generic bivalirudin formulations, is contributing to...
0 Comments 0 Shares 83 Views 0 Reviews